Q3 2025 · 13F-HR
Avidity Partners Management LPholdings as filed
Filed 2025-11-14 · accession 0001791827-25-000008
$439.4M
Reported value
43
Positions
2025-09-30
Period end
The Brief · Avidity Partners Management LP · Q3 2025
AI · grounded in 13F
Avidity Partners Management LP established a new position in Dianthus Therapeutics Inc DNTH valued at $126.1M. The fund also initiated a new stake in CG Oncology Inc CGON for $64.5M. Other new additions include Medtronic PLC MDT at $18.2M and Boston Scientific Corp BSX at $16.0M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $126.1M | 28.7% | 3,204,184 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $64.5M | 14.7% | 1,600,899 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $18.2M | 4.13% | 190,600 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $16.0M | 3.65% | 164,300 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $12.7M | 2.89% | 660,424 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $11.6M | 2.64% | 257,600 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $11.3M | 2.58% | 70,400 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $10.8M | 2.47% | 54,700 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $10.3M | 2.34% | 510,000 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $10.3M | 2.34% | 2,994,033 | Common | SOLE |
| 008064206 | JBIO | JADE BIOSCIENCES INC | $9.7M | 2.21% | 1,127,186 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $9.3M | 2.12% | 366,400 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $9.2M | 2.09% | 18,900 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $8.7M | 1.98% | 8,981,855 | Common | SOLE |
| 372303206 | GMAB | GENMAB A/S | $7.6M | 1.73% | 248,100 | Common | SOLE |
| 59267L107 | — | METSERA INC | $7.4M | 1.67% | 140,500 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $6.1M | 1.40% | 17,800 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $6.0M | 1.35% | 698,363 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $5.9M | 1.35% | 19,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $5.3M | 1.21% | 41,900 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $5.0M | 1.13% | 26,800 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $4.8M | 1.09% | 16,600 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $4.6M | 1.04% | 19,800 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $4.5M | 1.02% | 5,800 | Common | SOLE |
| 14280C105 | CARL | CARLSMED INC | $4.3M | 0.98% | 321,912 | Common | SOLE |
| 49177J102 | KVUE | KENVUE INC | $4.3M | 0.98% | 265,200 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $4.1M | 0.94% | 4,699,411 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $4.0M | 0.92% | 214,400 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $4.0M | 0.92% | 73,600 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $3.6M | 0.82% | 306,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $3.1M | 0.71% | 23,300 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $3.1M | 0.70% | 144,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.9M | 0.66% | 14,500 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $2.9M | 0.65% | 140,300 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $2.7M | 0.62% | 112,000 | Common | SOLE |
| 811292200 | SCYX | SCYNEXIS INC | $2.6M | 0.59% | 3,350,528 | Common | SOLE |
| 42226A107 | HQY | HEALTHEQUITY INC | $2.4M | 0.55% | 25,300 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $2.2M | 0.50% | 297,500 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $2.1M | 0.49% | 53,400 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $1.9M | 0.44% | 40,500 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $1.7M | 0.38% | 11,600 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $880,062 | 0.20% | 134,566 | Common | SOLE |
| 45254E107 | IMRX | IMMUNEERING CORP | $636,300 | 0.14% | 90,900 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.